<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04712825</url>
  </required_header>
  <id_info>
    <org_study_id>HYPNOVR-RIPH-2020-2</org_study_id>
    <nct_id>NCT04712825</nct_id>
  </id_info>
  <brief_title>Effect of Medical Hypnosis in Virtual Reality on Insomnia Disorders</brief_title>
  <acronym>EMERITE</acronym>
  <official_title>Effect of Medical Hypnosis in Virtual Reality on Insomnia Disorders: a Monocentric, Randomized, Open-label, Comparative Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>HypnoVR</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>HypnoVR</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The prevalence of chronic insomnia is 13.3% in France in 2019 (8.9 million). The consequences&#xD;
      for these people are multiple: drowsiness, memory problems, difficulty concentrating,&#xD;
      anxiety.&#xD;
&#xD;
      Cognitive and Behavioral Therapy (CBT) is today the reference treatment recommended by the&#xD;
      &quot;Haute Autorité de Santé&quot; and the American College of Physicians for chronic insomnia. Today,&#xD;
      however, few patients use CBT treatment due to the lack of trained practitioners, the cost of&#xD;
      non-reimbursed sessions and the time and involvement that these sessions require.&#xD;
&#xD;
      Several clinical trials have shown beneficial effects of hypnotherapy on sleep disorders. The&#xD;
      hypothesis of this work is that the use of hypnosis in virtual reality improves sleep time in&#xD;
      patients suffering from insomnia disorders.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 8, 2020</start_date>
  <completion_date type="Anticipated">July 8, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 8, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to sleep</measure>
    <time_frame>after 6 weeks of treatment</time_frame>
    <description>Demonstrate a decrease in time to sleep after treatment, by polysomnography</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Insomnia Chronic</condition>
  <arm_group>
    <arm_group_label>Cognitive-behavioural therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cognitive-behavioural therapy sessions</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Virtual Reality Hypnosis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Virtual Reality Hypnosis sessions</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive-behavioural therapy</intervention_name>
    <description>Cognitive-behavioural therapy sessions during 6 weeks of treatment</description>
    <arm_group_label>Cognitive-behavioural therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HypnoVR® device</intervention_name>
    <description>HypnoVR® sessions during 6 weeks of treatment</description>
    <arm_group_label>Virtual Reality Hypnosis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        1. Patient suffering from insomnia as defined in the Diagnostic and Statistical Manual of&#xD;
        Mental Disorders V (DMS-V) and the International Classification of Sleep Disorders.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patient who, in the judgment of the investigator, has a disease that may preclude&#xD;
             participation in study procedures.&#xD;
&#xD;
          2. Minor subject&#xD;
&#xD;
          3. Subject under judicial protection, guardianship or curatorship&#xD;
&#xD;
          4. Inability to give informed information about the subject: demented patients, psychotic&#xD;
             patients or follow-up for a psychiatric pathology&#xD;
&#xD;
          5. Unbalanced epilepsy&#xD;
&#xD;
          6. Hearing and/or visual disorders that contraindicate the use of virtual reality&#xD;
             headphones&#xD;
&#xD;
          7. Patient with a language barrier&#xD;
&#xD;
          8. Pregnant or breastfeeding patient&#xD;
&#xD;
          9. Subject in period of exclusion (determined by a previous or current study)&#xD;
&#xD;
         10. Patient Refusal&#xD;
&#xD;
         11. Patient currently being treated for depression, alcoholism or drug addiction.&#xD;
&#xD;
         12. Patient using drug treatment for insomnia not stabilized within 2 weeks prior to the&#xD;
             start of the study.&#xD;
&#xD;
         13. Patient starting psychological, complementary or alternative medicine treatment for&#xD;
             insomnia within 2 weeks prior to the start of the study, or during the study.&#xD;
&#xD;
         14. Patient receiving or having received CBT treatment for insomnia within the last 6&#xD;
             months.&#xD;
&#xD;
         15. Patient diagnosed with sleep apnea, involuntary limb movement, restless legs syndrome.&#xD;
&#xD;
         16. Patient with diagnosed medical conditions that cause insomnia: psychotic disorder,&#xD;
             bipolar disorder, dementia, generalized anxiety disorder, panic disorder, manic&#xD;
             disorder, schizophrenia, cancer.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Coralie GIANESINI, Dr</last_name>
    <phone>06 16 88 33 12</phone>
    <email>cg@hypnovr.io</email>
  </overall_contact>
  <location>
    <facility>
      <name>SELARL Respire</name>
      <address>
        <city>Haguenau</city>
        <zip>67500</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc Pfindel, Dr</last_name>
      <phone>06 08 93 60 40</phone>
      <email>drpfindel@orange.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>December 8, 2020</study_first_submitted>
  <study_first_submitted_qc>January 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 15, 2021</study_first_posted>
  <last_update_submitted>January 14, 2021</last_update_submitted>
  <last_update_submitted_qc>January 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Virtual reality</keyword>
  <keyword>Hypnosis</keyword>
  <keyword>Sleep</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

